$45 million in State Tax Credits Available to Growing California Companies
The California Competes Tax Credit is an income tax credit enacted last year (with the active support of Biocom) available to businesses that want to come to California or stay and grow in California. Tax credit agreements are negotiated by the Governor’s Office of Business and Economic Development (Go-Biz) under the direction of the “California Competes Tax Credit Committee,” consisting of the State Treasurer, the Director of the Department of Finance, the Director of GO-Biz, one appointee each by the Speaker of the Assembly and Senate Committee on Rules.
In the next round of awards, $45 million will be available competitively to California companies meeting the criteria established for the credits. The next application period for this credit will start on September 29, 2014, and close on October 27, 2014. More information can be found on the program and criterion for application here. The online application for the credit can be accessed here.
Join us at the Biocom Elected Officials and Candidates Reception
Meet CA Assembly Speaker Toni Atkins, Many More at the Biocom PAC Elected Officials and Candidates Reception
The life sciences industry faces numerous challenges and opportunities at all levels of government. As with any professional relationship, the key to successful advocacy is to have relationships with decision makers before you have an issue before them. The Biocom PAC Elected Officials and Candidates Reception is your opportunity to meet and chat with many of our elected officials in a relaxed, casual setting and build those connections so vital to the industry. As she has many times in the past, Speaker of the Assembly Toni Atkins of San Diego, one of the two most powerful legislators in the state, has already confirmed to join us for the event.
Elected officials and competitive candidates from the federal, state and selected local levels of government have been invited to meet our members and learn what is most critical to you. It is your opportunity to have your voice heard by those who affect the very way your company does business.
This year’s reception will be held at Celgene’s Campus Pointe campus on Tuesday, September 23, from 4:30pm to 6:30pm, with Genentech again generously being the Signature Sponsor and Celgene acting as our Host Sponsor. You may register or get more information here. We look forward to seeing you.
“One Region, One Voice” Washington DC trip
Biocom Vice President of Public Policy Jimmy Jackson was a participant in the San Diego Regional Chamber of Commerce’s Annual “One Region, One Voice” Washington DC trip. This is one of several strategic partners with whom Biocom participates in their general Washington DC visits. Pictured below are sessions with Congressmembers Darrell Issa and Scott Peters and a second session with Congressmembers Duncan Hunter and Susan Davis. Also participating in a dialogue session was Congressman Juan Vargas.
A common theme of all three sessions is that current San Diego delegation has gotten a great deal accomplished by working together for the benefit of the region; and in fact the relationship between the five is probably the most collegial and productive the region has had in recent memory. One example commonly cited was the recent approval of $216 million of federal funds to complete the expansion of the San Ysidro Port of Entry. All five local members supported the proposal, and the consensus of the group was that a call from Congressman Issa, who is a member of the Republican leadership of the House, was vital in securing these funds.
Biocom Submits Comments to Congress for 21st Century Cures Initiative
On September 8, 2014, Biocom sent comments to the House Energy & Commerce Committee in response to their request for stakeholders’ input on their 21st Century Cures Initiative. The initiative was launched in the spring and is intended to find ways to boost and improve our innovation ecosystem from discovery to development to delivery. Our comments specifically focus on digital health.
In the comments, Biocom highlighted the importance of digital health technologies, which hold promise for revolutionizing the delivery of care, and the challenges that the industry faces. In addition, Biocom offered a set of recommendations, including defining a clear framework for the regulation of digital health technologies, devising and implementing reimbursement policies that broaden coverage for new digital health technologies, developing the use of Electronic Health Records (EHRs) to modernize both the collection of clinical trial data and the delivery of care, and educating physicians and patients about these technological advances to ensure that they are aware of their benefits and properly trained to prescribe and use them.
Biocom looks forward to continuing working with the Energy & Commerce Committee as they draft comprehensive legislation. Click here to view the comments.
Biocom and ISPE Annual Facilities Reception
Tuesday, October 28th Biocom will be hosting itsannual Facilities Reception in partnership with the International Society forPharmaceutical Engineering (ISPE). This event is geared towards facilitymanagers and service providers but is open to all Biocom members. Mark yourcalendars for a relaxed evening to mingle with other facility managers andenjoy interaction with other organizations. For more information and toregister for the event, go here.
If you are interested in sponsoring this year’s reception,please contact Melanie Nally at 858-455-0300 x113 or email@example.com.